Generic Epclusa cost in India
Epclusa is essentially the be all universal or pan-genotype hepatitis C treatment and cost about $900 to $1200 in India, in the US it costs $75,000. epclusa cost in india
Epclusa is used to treat genotypes 1 to 6 chronic hepatitis C infection. As its predecessors Harvoni and Sovaldi, its a single pill a day for 84 days for most HCV patients.
All Hepatitis C Treatments come with a 100% Money Back Guarantee
Who can be treated with Epclusa?
Generic Epclusa is the first hepatitis C treatment that is available to treat genotypes 2 and 3 without ribavirin for most patients.
Making of Generic Epclusa:
Generic Epclusa is manufactured by Hetero Drugs, Natco and Cipla. The license from Gilead Sciences allows Indian pharmaceutical companies to manufacture the identical molecular compound of Epclusa that is available in the US.
Like generics of Harvoni, Sovaldi and Daklinza, Epclusa is a Direct Acting Antiviral (DAA). DAAs have been revolutionary in treating hepatitis C with or without the need for peg interferon-alpha and ribavirin.
Generic Epclusa Brand Names:
The most popular generic version of Epclusa is Velpanat from Natco pharmaceuticals in India. Other Indian manufacturers like Cipla, Mylan, Dr. Reddys, Abbott and several others are producing (Epclusa) velpatasvir 100mg and sofosbuvir 400mg tablets.
“Advanced cirrhosis means de-compensated liver that is extensively scarred and is not able to function properly.”
The average hepatitis C patient requires 12 weeks of treatment, 84 tablets of generic Epclusa for most prevalent genotypes in the US to be considered “cured”.
Your doctor will ask for a hepatitis C viral load test. The test will let your doctor know if its necessary to pursue treatment or not.
If the viral load is very low then most probably your physician will hold off on treatment, because of the $75,000 cost.
Your insurance company (technically) will only pay if you have a fibroscan of 3 and above.
Don’t wait to get lucky. If you have hepatitis C, get treated right away. Its affordable and accessible.
All generic versions of Harvoni , Sovaldi and Epclusa are manufactured under the license of Gilead Sciences and the FDA.
Want to talk to a health advocate, give us a call at 858-952-1077, fill the form or click on the bubble below and we’ll reply back right away.